Daily FNArena News

Following a meeting with management Moelis has reiterated a Buy rating on Thorn Group.

Spot uranium was lower last week but only marginally in the face of renewed global economic fears.

BIS Shrapnel’s Building in Australia 2011 report suggests Australian building commencements will recover from 2011/12, but a recovery in residential starts will take longer to develop.

Surprising as it may seem, ATW’s Jerry Simmons spotted some positive market signals for equities last week.

ResMed’s quarterly result showed enough positives to outweigh current forex pressures for a number of equity brokers.

Ahead of the Herd’s Rick Mills suggests junior gold stocks should be on the radar screen of every investor.

Weekly update on recommendation, target price, and earning forecast changes.

Change is coming. Ultimately, this will make us all a happier bunch.

An expected two-month payback from the Cadlao project in the Philippines is enough for DJ Carmichael to initiate coverage on junior oil play Raisama with a Spec Buy rating.

Aussie biotech junior Bionomics has received positive results from early trials of an anti-anxiety compound and Bell Potter sees enough potential upside to rate the stock a Speculative Buy.